REFLECTIONS OF A PHARMACIST, ACADEMIC AND RESEARCHER IN A PIVOTAL YEAR OF CHANGE FOR THE PHARMACY PROFESSION
Dr Kate Wang, Senior Lecturer in Pharmacy, RMIT University &
Adjunct Senior Lecturer, University of Western Australia
PEOPLE IN HEALTH CARE
Filmed in Melbourne, Victoria | December 2024
Dr. Kate Wang, a Senior Lecturer in Pharmacy at RMIT University and Adjunct Senior Lecturer, University of Western Australia, has over a decade of experience in both hospital and community pharmacy settings.
Dr Wang spoke to Australian Health Journal on some of the key topics in 2024 that have been pivotal as a pharmacist, academic and researcher for the pharmacy profession.
With Australia’s ageing population projected to reach 21-23% of those over 65 by 2060, the need for effective medication management is crucial. Older adults often face multiple chronic conditions and take multiple medications, making pharmacists essential as medication experts.
Pharmacists are the most accessible healthcare professionals in Australia, allowing for regular patient interactions. This consistent contact enables them to provide ongoing monitoring and health management, highlighting the importance of expanding their scope of practice. Dr. Wang emphasises the trialing of structured prescribing for conditions like uncomplicated urinary tract infections and oral contraceptives, where timely access is vital.
Attending the PSA24 conference hosted by the Pharmaceutical Society of Australia in Sydney, she noted the collaborative efforts among healthcare professionals to address changes in scope of practice. The process requires thorough review and piloting, with a commitment to patient centred care. As the field evolves, pharmacists must adapt to new treatments and emerging health challenges, continuously striving to make a positive impact on individuals and the broader community.
You Might also like
-
Being Part of the New Health Frontier
In November last year, the House of Representatives Standing Committee on Health, Aged Care and Sport delivered its bipartisan report “The New Frontier: Delivering better health for all Australians” on the approval processes for new drugs and novel medical technologies in Australia.
Australian Health Journal spoke to some of the industry bodies who were part of the Inquiry, for their comments on the process, the report and hopes in the recommendations being implemented.
-
Outstanding Achievement
George FaithfullGeorge has been in the medical device industry in a variety of roles for over 35 years including Sales, Marketing, Business Development, General Management, R&D, Clinical, Regulatory and Government Affairs. He has worked for Stryker in Australia, USA and across Asia.
-
MTAA MedTech19 Annual Conference
MTAA’s annual conference is the premier medical technology industry conference in Australia and brings together leaders and influencers across industry, government and academia to discuss what’s up ahead for the MedTech industry.